Azeliragon 5mg
TTP488-303
Phase 3 small_molecule terminated
Quick answer
Azeliragon 5mg for Alzheimer's Disease is a Phase 3 program (small_molecule) at vTv Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- vTv Therapeutics
- Indication
- Alzheimer's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated